Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

110.85
Delayed Data
As of Sep 22
 -4.20 / -3.65%
Today’s Change
83.01
Today|||52-Week Range
153.15
+10.55%
Year-to-Date

Today’s Trading

Previous close115.05
Today’s open114.36
Day’s range110.65 - 115.48
Volume2,174,810
Average volume (3 months)1,624,824
Market cap$23.4B
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-254.67%
Earnings growth (next 5 years)+92.90%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book49.91

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.08-0.12%
ALXNAlexion Pharmaceutic...-0.10-0.07%
BAXBaxter International...+0.13+0.21%
MYLMylan NV+0.06+0.19%
Data as of 4:04pm ET, 09/22/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts